$ZS

RUBIN KEVIN sold $1.1M of ZS

RUBIN KEVIN (Chief Financial Officer) sold 5,957 shares of Zscaler, Inc. (ZS) at $192.76 ($1.15M total) on 2026-09-16.

Original reporting
SEC EDGAR · RUBIN KEVIN
Published Sep 17, 2026, 11:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 11:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ZS
Bearish
medium confidence
Mentioned
$ZS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ZSBearishLow
01

Why it matters

The CFO's sale may be interpreted by investors as a lack of confidence, potentially prompting short‑term selling.

02

Market read

Insider sales are closely watched; this $1.1M sale is notable but not large enough to drive major market moves.

03

What to watch

No 10b5‑1 plan was used, indicating a discretionary decision.

Relevance 6/10Novelty 7/10Timing: post-market

Background

Form 4 filings disclose insider transactions and are primary sources of corporate insider activity.

Company-level read

Ticker impact

$ZSBearishMedium confidence
Context

CFO Kevin Rubin sold 5,957 shares of Zscaler for $1.15M, reducing his stake to 43,287 shares.

Expected impact

Modest downward pressure in the next trading session.

Evidence & confidence

Insider sales by senior executives often lead to slight sell‑offs, especially when the transaction size is over $1M.

Market effects

Minimal impact on the broader cybersecurity sector.

Limited to U.S. markets where Zscaler trades.

Low global relevance.

Counterpoint

The sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • Zscaler, Inc.

    Cybersecurity firm listed on NASDAQ.

  • Kevin Rubin

    Chief Financial Officer of Zscaler.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ZSMed

Zscaler (ZS) Sets $8B ARR Goal by FY2031 Amid Mixed Analyst View

Zscaler (ZS) aims to reach $8B in annual recurring revenue by FY2031, a 2.4x increase from current revenue. Analysts' views are mixed, with Morgan Stanley lowering its price target to $185 and UBS raising it to $250. The company's P/S ratio is 10.14x, below its historical median of 18.9x, reflecting market skepticism about growth and profitability.

$ZSMed

ZSCALER (ZS) Maintained by JP Morgan -- Price Target Raised to $

JP Morgan maintained an Overweight rating on Zscaler (ZS) and raised its price target from $215 to $245. The company's GF Value™ suggests it is 28.2% undervalued, with a GF Score™ of 76/100. Insider selling totaled $6.4M over the past three months. Zscaler operates in cloud-native cybersecurity, serving large enterprises and government agencies.

$ZSMed

ZS Maintained by Barclays -- Price Target Raised to $225

Barclays maintained an Overweight rating for Zscaler (ZS) and raised its price target to $225 from $220. GuruFocus values ZS at $296.22, suggesting a 29.1% undervaluation at its current price of $210.08. The company has a GF Score of 76/100, indicating strong growth and valuation but low profitability. Insider selling totaled $6.4M in the last 3 months.